Experimental Physiology
	

Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 90.5 pp 697-702
DOI: 10.1113/expphysiol.2005.030783
© The Physiological Society 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/697    most recent
expphysiol.2005.030783v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, M. J
Right arrow Articles by Cole, T. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, M. J
Right arrow Articles by Cole, T. J
Related Collections
Right arrow Symposia Papers
Right arrow Cardiovascular control

Symposium Report

Neural mechanisms in obesity-related hypertension

Central and peripheral contributions to obesity-associated hypertension: impact of early overnourishment

Margaret J Morris1, Elena Velkoska1 and Timothy J Cole2

1 Department of Pharmacology, The University of Melbourne, Parkville, Victoria 3010, Australia 2 Department of Biochemistry & Molecular Biology, Monash University, Clayton, Victoria 3800, Australia

Abstract

Obesity induced by a high-fat diet was associated with increased tail-cuff blood pressure in adult rats. The mechanisms underlying obesity-related hypertension are unclear, but increased sympathetic activation most probably plays a role. Neuroendocrine alterations observed in obesity may influence both feeding patterns and blood pressure. Work from our laboratory has shown that chronic overfeeding in rats leads to changes in neuropeptide Y (NPY) and {alpha}-melanocyte stimulating hormone ({alpha}MSH) in the hypothalamus. These peptides have central effects on blood pressure, indicating that obesity-related changes in the CNS may impact on cardiovascular function. Population studies suggest that nutrition in early life can influence the subsequent risk of obesity and high blood pressure. To examine the impact of early postnatal overnutrition on blood pressure and adipose-derived mediators, we adjusted rat litters to 3 or 12 pups (overnutrition and control, respectively). Pups raised in small litters were 15% heavier at weaning, and this intervention was associated with a modest elevation of blood pressure and body weight as adults (16 weeks). Animals raised in small litters had increased 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) mRNA in white adipose tissue as adults, which may impact on cardiovascular function. Adjustment of diet after weaning, to 30% fat diet or standard chow, allowed comparison of the impact of different periods of overnourishment. Implementation of a high-fat diet at weaning overcame the effect of litter size on body weight from 10 weeks of age. Blood pressure rose progressively with high-fat feeding and was positively correlated with leptin and body weight. Chronic consumption of a high-fat diet led to marked increases in leptin and insulin and modest increases in blood pressure, and impacts on brain transmitters implicated in the regulation of both appetite and blood pressure. Overnourishment during early postnatal development led to profound changes in body weight at weaning, which tended to abate with maturation. It also led to long-term changes in some adipose-derived mediators, possibly increasing cardiovascular risk.

(Received 5 June 2005; accepted after revision 6 July 2005; first published online 16 August 2005)
Corresponding author M. J. Morris: Department of Pharmacology, The University of Melbourne, Victoria 3010, Australia. Email: mjmorris{at}unimelb.edu.au

Cardiovascular impact of obesity

Obesity is a health problem of increasing prevalence in every continent and represents a major public health concern. While many studies indicate that obesity is a major risk factor for cardiovascular morbidity and mortality, the relationship between obesity and hypertension is unclear and could reflect genetic, environmental, hormonal and haemodynamic factors (Redon, 2001).

As discussed in this issue, much interest has focused on the potential role of sympathetic activation in obesity-related hypertension. The sympathetic system adapts to changes in dietary caloric intake, with sympathetic nervous activation and inhibition accompanying caloric excess or deficiency, respectively (Rumantir et al. 1999). Chronic overeating in rodents stimulated the sympathetic nervous system, resulting in elevated blood pressure (Landsberg & Krieger, 1989). While obesity-induced hypertension has been linked to hyperinsulinaemia-induced activation of the sympathetic nervous system (Mikhail et al. 1999), another important contribution to obesity-related hypertension is the adipocyte-derived hormone, leptin, which circulates at levels proportional to fat mass. The actions of leptin are mediated by leptin receptors (Ob-Rb) found predominantly in the hypothalamus, which regulate the production of orexigenic and anorexigenic peptides. Particularly important in the central regulation of feeding is the orexigenic transmitter, neuropeptide Y (NPY), which has potent stimulatory effects on food intake. NPY exerts its major feeding effect in the paraventricular nucleus of the hypothalamus (PVN). In addition to its regulatory effects on feeding, leptin administration can increase sympathetic activity and blood pressure (Shek et al. 1998; Dunbar & Lu, 1999; Rahmouni & Haynes, 2004). Furthermore, leptin may also affect blood pressure by inhibiting NPY synthesis, and we have shown that leptin can reduce NPY release from the hypothalamus and medulla (Lee & Morris, 1998). Microinjections of NPY into the nucleus tractus solitarii (NTS), a medullary region that integrates cardiovascular signals, elicits a dose-dependent fall in blood pressure and heart rate (Morris et al. 1997).

As shown in Fig. 1, other circulating hormones, and mediators produced by adipose tissue, have the potential to regulate blood pressure via the modulation of vascular tone or intravascular volume (Lyon et al. 2003; Rajala & Scherer, 2003; Fruhbeck, 2004). Adipocytokines such as adiponectin, which is decreased in human obesity, interleukin-6 (Il-6) and tumour necrosis factor {alpha} (TNF-{alpha}) released from adipose tissue, can contribute to endothelial dysfunction, thereby increasing the risk of atherosclerosis (Lyon et al. 2003). In addition, the enzyme 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1), and angiotensinogen, are expressed by adipose tissue and these may play a key role in the cardiovascular risk associated with visceral obesity. 11ß-HSD1 converts cortisone to its active form, cortisol. Transgenic mice overexpressing 11ß-HSD1 in adipose tissue have hypertension accompanied by visceral fat accumulation, and insulin and leptin resistance (Masuzaki et al. 2003).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 1.  Obesity is associated with alterations in hormones and mediators derived from adipose tissue, which may impact on blood pressure (BP) and vascular function
Sympathetic activation and baroreceptor dysfunction both impact on BP. Leptin from adipose tissue, insulin and angiotensin II (AngII) can increase sympathetic activity, thus raising BP. Adipose-derived 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1) promotes conversion of cortisone to active cortisol. Reduced adipose-derived adiponectin, and increased interleukin 6 (IL-6) and tumour necrosis factor {alpha} (TNF-{alpha}), would favour atherosclerosis. Ghrelin may influence BP regulation, since it has been shown to exert depressor effects in the CNS.

 
Adult-onset obesity

In order to investigate the link between obesity and hypertension our laboratory has developed palatable high-fat diets for rodents that can be applied in young adulthood, allowing us to examine the cardiovascular/metabolic consequences of voluntary overfeeding (Hansen et al. 2001, 2004). Weight-matched (200 g) groups of male rats received standard chow (12% calories as fat) or a highly palatable cafeteria-style diet (consisting of supplemented chow, meat pies, pasta and cakes, 30% calories as fat; Hansen et al. 2004). Animals can be followed for various periods of dietary intervention (Hansen et al. 2001, 2004). Blood pressure measurements by plethysmography, as well as tail vein blood samples, are taken at regular intervals. While body weight, fat mass and plasma leptin increase soon after implementation of the diet (Hansen & Morris, 2002), increases in blood pressure only become apparent after 10 weeks or so. Hypothalamic NPY levels decreased with chronic high-fat feeding and we observed significant negative correlations between total hypothalamic NPY and plasma leptin (Hansen & Morris, 2002).

Childhood obesity

Childhood obesity is also increasing throughout the world (Kohn & Booth, 2003; Slyper, 2004) and demographic data suggest that environmental influences operating early in life are involved. Childhood obesity is associated with subsequent hyperlipidaemia, glucose intolerance and hypertension (Caprio et al. 1996). Many of the cardiovascular consequences that characterize adult obesity are preceded by abnormalities that begin in childhood. Managing childhood obesity and its consequences requires an understanding of the underlying pathophysiological changes of early-onset obesity. In rodents, reducing litter size postnatally increases food availability and is used to study the consequences of early overnutrition (Plagemann et al. 1999). In the following section we describe studies from our laboratory in which we investigated the long-term metabolic and cardiovascular consequences of preweaning overnourishment, which to date have been little examined.

In addition to examining the chronic impact of a short period of overnourishment (using litter adjustment), we have also examined the impact of continuous overnutrition from birth, induced by small litter size followed by a high-fat diet.

Modelling early-onset obesity

Litter adjustment

Methods used to model early-onset overnourishment are shown in Fig. 2. On day 1 of life, rat pup litters were adjusted to 3 (small litter) or 12 male animals (normal litter) of similar body weights, to induce early postnatal overnutrition or normal nutrition, respectively. Animals in the small litters were significantly heavier than those in normal litters by day 14 (41.1 ± 0.8 versus 32.9 ± 0.5 g, P < 0.001). At 24 days of age the pups raised in small litters were 15% heavier than those in normal litters (80.7 ± 1.3 versus 70.0 ± 0.9 g, P < 0.001). This increase in body weight was associated with a 20–30% increase of milk consumption in animals in small litters. Leptin levels were more than doubled at weaning in these animals and remained significantly increased at 8 weeks of age, while animals were consuming low-fat chow (Fig. 3A). At 16 weeks there was no significant difference in plasma leptin (Fig. 3A). When Northern blot analysis for 11ß-HSD1 expression in retroperitoneal white adipose tissue was undertaken at 16 weeks of age, increased 11ß-HSD1 mRNA was observed in rats raised in small litters (Fig. 3B). This suggests that there may be some long-term effects of early-onset overnutrition on 11ß-HSD1, possibly representing a programming effect of early overnutrition.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 2.  Experimental protocol of early nutritional intervention
Litter sizes are adjusted to 12 (control) and 3 (overnourished) pups per mother. At weaning, rats have either ad libitum access to a palatable high-fat diet (30% calories as fat) or a standard chow diet (12% calories as fat). Body weight, food intake and blood pressure are measured at regular intervals, and hypothalamic neuropeptide Y, plasma hormones and adipose-derived mediators are analysed.

 


View larger version (21K):
[in this window]
[in a new window]
 
Figure 3.  Plasma leptin concentrations at weaning, 8 and 16 weeks of age (A) and 11ß-HSD1 mRNA expression in retroperitoneal white adipose tissue (B) at 16 weeks of age in rats from normal ({square}) and small litters ({blacksquare}) fed chow
Results are expressed as means ± S.E.M. of the relative expression of 11ß-HSD1 to GAPDH. Data were analysed using Student's unpaired t test. *P < 0.05, ***P < 0.001.

 
While body weight did not remain significantly elevated at 16 weeks after overnourishment as pups, we consistently observed a 5% higher body weight in rats raised in small litters; depending on the particular cohort, modest elevations in tail-cuff blood pressure of around 10 mmHg have been observed. On a population basis, relatively small changes such as these may be relevant to cardiovascular disease.

Litter adjustment, followed by normal or high-fat diet

In a subsequent study, at weaning (day 24), pups of both litter sizes were divided into groups receiving standard chow (12% calories as fat) or high-fat diet (30% calories as fat; see Fig. 2). Animals raised in small litters were significantly heavier than those in normal litters, regardless of their diet (Fig. 4A; Velkoska et al. 2005). However, from 11 weeks of age there was no significant effect of litter size on body weight (Fig. 4A). Plasma leptin was elevated in animals in small litters compared to those in normal litters at 8 weeks of age, irrespective of their postweaning diet (Fig. 4B), suggesting that early overnourishment has long-lasting effects on body fat. At 16 weeks of age organ weights and fat mass of the animals in small litters tended to be slightly heavier than those from normal litters, but these differences did not reach significance (Velkoska et al. 2005). Again, there was a modest 4–5% litter size-related increase in body weight in both diet groups.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 4.  Body weight and plasma leptin concentrations post weaning
A, body weight after weaning of rats from normal litter chow fed (NC, n = 11; {square}), normal litter high-fat fed (NF, n = 11; {blacksquare}), small litter chow fed (SC, n = 12; {circ}) and small litter high-fat fed (SF n = 10; •). Data were analysed by two-way ANOVA with repeated measures followed by post hoc least significant difference test. B, plasma leptin concentrations up to 16 weeks of age in NC (open bar), SC (lightly shaded bar), NF (darker shaded bar) and SF (filled bar). Data were analysed with two-way ANOVA followed by post hoc Bonferroni test. Results are expressed as means ± S.E.M. {dagger} P < 0.05, significant difference between litter groups; *P < 0.05, ***P < 0.001 significant difference within litter groups (i.e. diet effect). Adapted from Velkoska et al. (2005); used with permission.

 
As we have observed with adult-onset high-fat feeding, body weight increased within 2 weeks of implementation of the high-fat diet postweaning (Fig. 4A), and body weight remained greater in animals fed the high-fat diet throughout the study (Fig. 4A). At 16 weeks of age, high-fat-fed rats from both litter groups were 20% heavier than their chow-fed counterparts, and consumed twice as much energy (Velkoska et al. 2005). Even after standardization for body weight the high-fat-fed rats had more adipose tissue (Velkoska et al. 2005). Similar to adult-onset dietary obesity (Hansen et al. 2004), ingestion of a high-fat diet postweaning led to a more than doubling of plasma leptin from 8 weeks of age (4–5 weeks diet; Fig. 4B).

Diet-related increases in systolic blood pressure appear to be delayed relative to increases in body weight and plasma leptin. While blood pressure was similar in all treatment groups at 7 weeks of age, increases in blood pressure of 11–20 mmHg were evident in both high-fat-fed groups relative to chow-fed controls at 13 weeks (Velkoska et al. 2005). When high-fat and chow diet rats were combined, blood pressure was positively correlated with plasma leptin and with plasma insulin at 13 weeks of age in each litter group (Velkoska et al. 2005). Significant reductions in hypothalamic NPY (including PVN) were observed at 16 weeks in response to the high-fat diet. In addition, a significant negative correlation was apparent between leptin and total hypothalamic NPY in both litter size groups (Velkoska et al. 2005).

Impact of early overnutrition

Although overnutrition in critical periods of development is suggested to confer increased risk of subsequent obesity and metabolic disorders, the relationship between the timing of onset of overeating and the risk of obesity is unclear. In our hands, postnatal overnutrition induced by small litter size led to early changes in body weight, most probably related to increased milk consumption. This impact of small litter size to increase body weight was maintained for a period into young adulthood (10 weeks), in accordance with previous studies (Faust et al. 1980; Plagemann et al. 1999) which showed increased fat mass and fat cell number as a result of early overnutrition. Our work demonstrates the development of marked hyperleptinaemia in the animals in small litters along with the greater body weight gain. It is also possible that early environmental effects related to the alteration in litter size, such as altered mother–pup interaction, may impact on subsequent behaviour and stress response. Earlier work showed that handling of pups led to increased maternal care (licking and grooming), and that this was associated with dampened hypothalmo–pituitary–adrenal responsivity to stress as adults (Liu et al. 1997).

We have also examined the effect of prolonging the early-onset overnourishment by subjecting animals to a high-fat diet postweaning. Regardless of litter size, the high-fat diet resulted in a significant increase in body weight compared to chow diet after only 2 weeks. We observed diet-induced hyperleptinaemia and hyperinsulinaemia, as well as significant increases in fat mass. These findings demonstrate that long-term feeding of a high-fat diet can override early litter size-induced effects, indicating the importance of overnutrition in later life (Velkoska et al. 2005). However, the animals raised in the small litters remained moderately heavier than those raised in normal litters throughout adulthood, although this failed to reach significance. This suggests that early nutrition may still play a small but important role.

What links obesity and blood pressure?

Adjustment of litter size in rats, thereby influencing early feeding patterns, can influence adult blood pressure (Myers et al. 1996; Plagemann et al. 1999), as can the type of diet. We have looked at this question in two ways. First, implementation of a high-fat diet (either as an adult or at weaning) led to early and marked increases in body weight and leptin concentrations; these were associated with modest increases in systolic blood pressure that were manifest after several months. Second, overfeeding rats for a limited period from a very early age (day 1–24) also led to prolonged increases in body weight, and leptin concentrations remained elevated long after a normal diet was implemented postweaning. The effect of short-term overnutrition, induced by reducing litter size, on blood pressure requires further investigation in suitably powered studies.

Early work has shown that high caloric intake can increase sympathetic activity, thus increasing noradrenaline turnover in peripheral tissues and raising resting plasma noradrenaline, resulting in elevated blood pressure (Landsberg & Krieger, 1989). Studies in humans suggest that there may be vascular bed-specific increases in sympathetic activity rather than an overall increased sympathetic drive. Obesity-related increases in blood pressure have been associated with hyperleptinaemia (Rahmouni & Haynes, 2004) and increased sympathetic activity to the interscapular brown adipose tissue (iBAT), kidney and adrenal gland. Recent studies have shown that microinjection of leptin into discrete hypothalamic regions, such as the ventromedial or dorsomedial hypothalamus, led to differential effects on sympathetic vasomotor tone (Marsh et al. 2003), suggesting that sympathetic activation due to leptin is mediated via the central nervous system. Other observations support this suggestion, since lesion of the arcuate nucleus abolished the sympathetic response to leptin infusion (Haynes, 2000). In contrast, injections of NPY into the third ventricle or the PVN results in decreased sympathetic activity to iBAT (Egawa et al. 1991). The potential contribution to altered cardiovascular control of the reduction in hypothalamic NPY that we consistently observe in chronic dietary obesity is unknown, and warrants investigation.

Another important consideration is the distribution of the adipose tissue in obese subjects. Central obesity was shown to be associated with greater sympathetic activation relative to peripheral obesity, with equivalent impairment in baroreflex control (Grassi et al. 2004). Another report found no elevation in muscle sympathetic nerve activity in men with subcutaneous obesity (Alvarez et al. 2004) despite elevated leptin concentrations. The mechanism whereby regional fat deposition confers different cardiovascular risk is intriguing. In a previous study we observed increased mRNA levels of 11ß-HSD1 in retroperitoneal white adipose tissue in adult rats that were overnourished as young pups (Velkoska et al. 2005). It has been speculated that increased glucocorticoid production as a result of increased 11ß-HSD1 mRNA in adipose tissue in obese humans may influence fat accumulation (Rask et al. 2002).

Children who have higher body mass are more likely to become obese adults and are at higher risk of developing cardiovascular disturbances (Gunnell et al. 1998; Jeffreys et al. 2003). Rats overfed from an early age developed increases in body weight, along with changes in the mediators involved in the both the regulation of feeding and blood pressure. Further research is required to increase our understanding of the mechanisms underlying the development of increased blood pressure in obesity.

References

Alvarez GE, Ballard TP, Beske SD & Davy KP (2004). Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol 287, H414–H418.

Caprio S, Hyman LD, McCarthy S, Lange R, Bronson M & Tamborlane WV (1996). Fat distribution and cardiovascular risk factors in obese adolescent girls: importance of the intraabdominal fat depot. Am J Clin Nutr 64, 12–17.[Abstract/Free Full Text]

Dunbar JC & Lu H (1999). Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull 50, 215–221.[CrossRef][Medline]

Egawa M, Yoshimatsu H & Bray GA (1991). Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol 260, R328–R334.

Faust IM, Johnson PR & Hirsch J (1980). Long-term effects of early nutritional experience on the development of obesity in the rat. J Nutr 110, 2027–2034.

Fruhbeck G (2004). The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2, 197–208.[CrossRef][Medline]

Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB & Mancia G (2004). Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 22, 2363–2369.[CrossRef][Medline]

Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ & Davey Smith G (1998). Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 67, 1111–1118.[Abstract]

Hansen MJ, Ball MJ & Morris MJ (2001). Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892, 130–137.[CrossRef][Medline]

Hansen MJ, Jovanovska V & Morris MJ (2004). Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem 88, 909–916.[Medline]

Hansen MJ & Morris MJ (2002). Evidence for an interaction between neuropeptide Y and the melanocortin-4 receptor on feeding in the rat. Neuropharmacology 42, 792–797.[CrossRef][Medline]

Haynes WG (2000). Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep 2, 311–318.[Medline]

Jeffreys M, McCarron P, Gunnell D, McEwen J & Smith GD (2003). Body mass index in early and mid-adulthood, and subsequent mortality: a historical cohort study. Int J Obes Relat Metab Disord 27, 1391–1397.[CrossRef][Medline]

Kohn M & Booth M (2003). The worldwide epidemic of obesity in adolescents. Adolesc Med 14, 1–9.[Medline]

Landsberg L & Krieger DR (1989). Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 2, 125S–132S.[Medline]

Lee J & Morris MJ (1998). Modulation of neuropeptide Y overflow by leptin in the rat hypothalamus, cerebral cortex and medulla. Neuroreport 9, 1575–1580.[Medline]

Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A et al. (1997). Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277, 1659–1662.[Abstract/Free Full Text]

Lyon CJ, Law RE & Hsueh WA (2003). Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144, 2195–2200.[Abstract/Free Full Text]

Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW & Dampney RA (2003). Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 42, 488–493.[Abstract/Free Full Text]

Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM et al. (2003). Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112, 83–90.[CrossRef][Medline]

Mikhail N, Golub MS & Tuck ML (1999). Obesity and hypertension. Prog Cardiovasc Dis 42, 39–58.[CrossRef][Medline]

Morris MJ, Hastings JA & Pavia JM (1997). Central interactions between noradrenaline and neuropeptide Y in the rat: implications for blood pressure control. Clin Exp Hypertens 19, 619–630.

Myers MM, Handler-Matasar SR & Shair HN (1996). Effects of neonatal growth on adult blood pressures of borderline hypertensive rats. Hypertension 27, 96–101.[Abstract/Free Full Text]

Plagemann A, Harder T, Rake A, Voits M, Fink H et al. (1999). Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Res 836, 146–155.[CrossRef][Medline]

Rahmouni K & Haynes WG (2004). Leptin and the cardiovascular system. Recent Prog Horm Res 59, 225–244.[Abstract/Free Full Text]

Rajala MW & Scherer PE (2003). Minireview: The adipocyte – at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765–3773.[Abstract/Free Full Text]

Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O et al. (2002). Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87, 3330–3336.[Abstract/Free Full Text]

Redon J (2001). Hypertension in obesity. Nutr Metab Cardiovasc Dis 11, 344–353.[Medline]

Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR et al. (1999). Neural mechanisms in human obesity-related hypertension. J Hypertens 17, 1125–1133.[CrossRef][Medline]

Shek EW, Brands MW & Hall JE (1998). Chronic leptin infusion increases arterial pressure. Hypertension 31, 409–414.[Abstract/Free Full Text]

Slyper AH (2004). The pediatric obesity epidemic: causes and controversies. J Clin Endocrinol Metab 89, 2540–2547.[Abstract/Free Full Text]

Velkoska E, Cole TJ & Morris MJ (2005). Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers. Am J Physiol 288, E1236–E1243.

Acknowledgements

This work was supported by a Postgraduate Scholarship from the National Heart Foundation of Australia (E.V.) and a Project Grant from the National Health and Medical Research Council, Australia (M.J.M.).




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. J. Spencer, A. Mouihate, M. A. Galic, S. L. Ellis, and Q. J. Pittman
Neonatal immune challenge does not affect body weight regulation in rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R581 - R589.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. A. L Dampney
Neural mechanisms in obesity-related hypertension
Exp Physiol, September 1, 2005; 90(5): 671 - 671.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/697    most recent
expphysiol.2005.030783v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, M. J
Right arrow Articles by Cole, T. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, M. J
Right arrow Articles by Cole, T. J
Related Collections
Right arrow Symposia Papers
Right arrow Cardiovascular control


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS